Malachite Innovations, Inc. (VBIO) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Los Angeles, CA, United States. The current CEO is Michael R. Cavanaugh CPA,.
VBIO has IPO date of 2022-01-31, 3 full-time employees, listed on the Other OTC.
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.
